Cargando…
Rare variant in the fumarate hydratase gene found in patients with clinical features of hereditary leiomyomatosis and renal cell cancer (HLRCC): A case series
Hereditary leiomyomatosis and renal cell cancer (HLRCC) is an inherited cancer predisposition syndrome caused by autosomal dominant heterozygous pathogenic variants in the fumarate hydratase (FH) gene. FH pathogenic variant carriers are at an increased risk for cutaneous leiomyomas, renal cell cance...
Autores principales: | Franke, Keith, Vagher, Jennie, Boyle, Julie, Hall, April, Smith‐Simmer, Kelcy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8886725/ https://www.ncbi.nlm.nih.gov/pubmed/35251648 http://dx.doi.org/10.1002/ccr3.5513 |
Ejemplares similares
-
A Missense Mutation c.1132G > A in Fumarate Hydratase (FH) Leads to Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC) Syndrome and Insights into Clinical Management in Uterine Leiomyomata
por: Shi, Yue, et al.
Publicado: (2023) -
Hereditary leiomyomatosis and renal cell cancer (HLRCC): A case report
por: Yonamine, Tomoko, et al.
Publicado: (2020) -
Fumarate hydratase inactivation in hereditary leiomyomatosis and renal cell cancer is synthetic lethal with ferroptosis induction
por: Kerins, Michael J., et al.
Publicado: (2018) -
Cutaneous and uterine leiomyomatosis and ovarian cystadenoma associated with deficiency of fumarate hydratase
por: Hüller, Cornelia, et al.
Publicado: (2011) -
Novel Fumarate Hydratase Mutation in Siblings With Early Onset Uterine Leiomyomas and Hereditary Leiomyomatosis and Renal Cell Cancer Syndrome
por: Gunnala, Vinay, et al.
Publicado: (2018)